(NASDAQ: LNSR) Lensar's forecast annual revenue growth rate of 21.96% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.75%.
Lensar's revenue in 2025 is $59,141,000.On average, 4 Wall Street analysts forecast LNSR's revenue for 2025 to be $763,901,495, with the lowest LNSR revenue forecast at $733,944,574, and the highest LNSR revenue forecast at $786,369,186. On average, 4 Wall Street analysts forecast LNSR's revenue for 2026 to be $1,038,028,826, with the lowest LNSR revenue forecast at $997,321,813, and the highest LNSR revenue forecast at $1,068,559,085.
In 2027, LNSR is forecast to generate $1,352,361,498 in revenue, with the lowest revenue forecast at $1,299,327,714 and the highest revenue forecast at $1,392,136,836.